AL Amyloidosis (Amyloidosis Antibody Light). Part 1. Definition, Classification, Amyloid Structure, Development and Etiopathogenesis of AL Amyloidosis

被引:0
|
作者
Usnarska-Zubkiewicz, Lidia [1 ]
Holojda, Jadwiga [2 ]
Kuliczkowski, Kazimierz [1 ]
机构
[1] Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, PL-50367 Wroclaw, Poland
[2] Dist Specialist Hosp Legnica, Dept Hematol, Legnica, Poland
来源
关键词
amyloidosis AL; classification; amyloid structure; etiopathogenesis; PRIMARY SYSTEMIC AMYLOIDOSIS; ORGAN INVOLVEMENT; GENE USE; CHAINS; ASSOCIATION; SURVIVAL; TRANSLOCATIONS; PROTEINS; CELLS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Amyloidosis is an inherited or acquired systemic storage disease in which a pathologic, amorphous substance produced as a result of abnormal protein metabolism and resistant to proteolysis is deposited in the extracellular space of various tissues (intracellular deposits occur rarely). This leads to the destruction of normal tissue architecture and disturbs its function. The development of amyloidosis is associated with the transformation of the alpha-spiral conformation of fibrous protein into a stratified, parallel, folded spatial beta-conformation. The transition of the fibrous proteins conformation and their tissue localization causes resistance of the fibers to proteolytic processes as a result of a limited access of the protein converting enzymes. In this paper we show the actual classification of amyloidosis and up-to-date knowledge about the amyloid structure, development and etiopathogenesis of AL amyloidosis (Adv Clin Exp Med 2011, 20, 5, 647-652).
引用
收藏
页码:647 / 652
页数:6
相关论文
共 50 条
  • [31] Light Chain (AL) Amyloidosis: The Journey to Diagnosis
    Kristen L. McCausland
    Michelle K. White
    Spencer D. Guthrie
    Tiffany Quock
    Muriel Finkel
    Isabelle Lousada
    Martha S. Bayliss
    [J]. The Patient - Patient-Centered Outcomes Research, 2018, 11 : 207 - 216
  • [32] Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis
    Palladini, Giovanni
    Schoenland, Stefan O.
    Sanchorawala, Vaishali
    Kumar, Shaji
    Wechalekar, Ashutosh
    Hegenbart, Ute
    Milani, Paolo
    Ando, Yukio
    Westermark, Per
    Dispenzieri, Angela
    Merlini, Giampaolo
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (01): : 1 - 2
  • [33] AL amyloidosis response: a move in the "light" direction
    Dispenzieri, Angela
    [J]. BLOOD, 2024, 143 (13) : 1204 - 1206
  • [34] Primary Hepatic Amyloidosis: An Uncommon Presentation of Systemic Immunoglobulin Light Chain (AL) Amyloidosis
    Garner, Jessica
    Ramirez, Jonathan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S957 - S957
  • [35] Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis
    Elad, Sharon
    Czerninski, Rakefet
    Fischman, Stuart
    Keshet, Na'ama
    Drucker, Scott
    Davidovich, Tzipporah
    Goldschmidt, Neta
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 (01): : 27 - 31
  • [36] CT features of isolated pulmonary amyloid light-chain (AL) amyloidosis
    Lecomte, Adrien
    Olejarz, Nicole
    Canniff, Emma
    [J]. DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2024, 105 (03) : 121 - 122
  • [37] How We Manage Systemic Immunoglobulin Heavy Chain Amyloidosis (AH Amyloidosis) and Immunoglobulin Heavy-and-Light-Chain Amyloidosis (AH/AL Amyloidosis)
    Chaulagain, Chakra P.
    Herlitz, Leal C.
    Fu, Julie
    Bilani, Nadeem
    Lucitt, Camerun
    Comenzo, Raymond L.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (11): : E826 - E831
  • [38] Preclinical development of siRNA therapeutics for AL amyloidosis
    Hovey, B. M.
    Ward, J. E.
    Hoo, P. Soo
    O'Hara, C. J.
    Connors, L. H.
    Seldin, D. C.
    [J]. GENE THERAPY, 2011, 18 (12) : 1150 - 1156
  • [39] AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis
    Shun Manabe
    Chihiro Iwasaki
    Michiyasu Hatano
    Fuyuki Kametani
    Masahide Yazaki
    Kosaku Nitta
    Michio Nagata
    [J]. BMC Nephrology, 19
  • [40] AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis
    Manabe, Shun
    Iwasaki, Chihiro
    Hatano, Michiyasu
    Kametani, Fuyuki
    Yazaki, Masahide
    Nitta, Kosaku
    Nagata, Michio
    [J]. BMC NEPHROLOGY, 2018, 19